170 related articles for article (PubMed ID: 32627014)
1. Propofol‑induced miR‑125a‑5p inhibits the proliferation and metastasis of ovarian cancer by suppressing LIN28B.
Zeng J; Li YK; Quan FF; Zeng X; Chen CY; Zeng T; Zou J; Tong WJ
Mol Med Rep; 2020 Aug; 22(2):1507-1517. PubMed ID: 32627014
[TBL] [Abstract][Full Text] [Related]
2. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
[TBL] [Abstract][Full Text] [Related]
3. Propofol suppresses gastric cancer tumorigenesis by modulating the circular RNA‑PVT1/miR‑195‑5p/E26 oncogene homolog 1 axis.
Sui H; Zhu C; Li Z; Yang J
Oncol Rep; 2020 Oct; 44(4):1736-1746. PubMed ID: 32945521
[TBL] [Abstract][Full Text] [Related]
4. Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR-328 and down-regulating ADAM8.
Yu X; Gao Y; Zhang F
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):271-278. PubMed ID: 30861616
[TBL] [Abstract][Full Text] [Related]
5. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis.
Lu H; Zheng G; Gao X; Chen C; Zhou M; Zhang L
J Ovarian Res; 2021 Feb; 14(1):30. PubMed ID: 33563314
[TBL] [Abstract][Full Text] [Related]
6. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑125a‑5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1.
Zha Z; Li J
Int J Mol Med; 2020 Nov; 46(5):1849-1861. PubMed ID: 33000203
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
9. CircNFIX stimulates the proliferation, invasion, and stemness properties of ovarian cancer cells by enhancing SH3RF3 mRNA stability via binding LIN28B.
Yu XZ; Yang BW; Ao MY; Wu YK; Ye H; Wang RY; Xi MR; Hou MM
Kaohsiung J Med Sci; 2023 Mar; 39(3):234-243. PubMed ID: 36495291
[TBL] [Abstract][Full Text] [Related]
10. miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.
Li D; Chen L; Zhang X; Wang Y; Huang C; Li J; He F; He W
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34549308
[TBL] [Abstract][Full Text] [Related]
11. Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal.
Huang X; Teng Y; Yang H; Ma J
Braz J Med Biol Res; 2016 Dec; 49(12):e5717. PubMed ID: 27982283
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
[TBL] [Abstract][Full Text] [Related]
13. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 3A inhibits tumor progression via the downregulation of Lin28B in ovarian cancer.
Ma RY; Yang LN; Chen JN; Chen RJ; Zhang LW; Wang XQ
Neoplasma; 2023 Feb; 70(1):103-113. PubMed ID: 36660796
[TBL] [Abstract][Full Text] [Related]
15. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
16. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
Kang M; Lee KH; Lee HS; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2017; 12(9):e0184644. PubMed ID: 28910332
[TBL] [Abstract][Full Text] [Related]
17. Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk.
Hu C; Iwasaki M; Liu Z; Wang B; Li X; Lin H; Li J; Li JV; Lian Q; Ma D
J Adv Res; 2021 Jul; 31():1-12. PubMed ID: 34194828
[TBL] [Abstract][Full Text] [Related]
18. The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway.
Fan X; Liang Y; Liu Y; Bai Y; Yang C; Xu S
Int J Oncol; 2018 Jul; 53(1):148-158. PubMed ID: 29750426
[TBL] [Abstract][Full Text] [Related]
19. DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancer.
Huang J; Cao D; Sha J; Zhu X; Han S
Biochem Biophys Res Commun; 2019 Jun; 514(3):853-860. PubMed ID: 31079917
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]